Virbac S.A. (VIRP.PA)
Virbac S.A. operates in the Drug Manufacturers - General industry of the Healthcare sector, headquartered in Carros, PA, FR. The stock last traded at $333.50, down 1.91% on the session, giving a market capitalisation of $2.79B. Its beta of 0.78 implies it has historically moved less than the broad market.
Founded in 1968 and based in Carros, France, Virbac S.A. is a prominent developer and distributor of a wide array of animal health products and services. The company's global operations extend across France, Europe, Latin America, North America, Asia Pacific, the Middle East, and Africa, catering to both domestic companion animals and commercial livestock. Its extensive portfolio encompasses vaccines, dental hygiene products, reproductive health solutions, dermatological treatments, parasiticides, diagnostic instruments, antibiotics, and aquaculture offerings. Furthermore, Virbac supplies specialized veterinary pharmaceuticals for anesthesia, geriatric care, behavioral management, and injectable micronutrients, alongside pet food and electronic identification systems. These diverse solutions are designed to support veterinarians, agricultural producers, and individual pet owners worldwide.
Virbac S.A. is most often compared with the following Healthcare names: